AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 3 642-R648, Copyright © 1991 by American Physiological Society

ARTICLES

Renal and humoral responses to sustained cardiopulmonary baroreceptor deactivation in humans

J. A. Miller, J. S. Floras, K. L. Skorecki, L. M. Blendis and A. G. Logan
Department of Medicine, University of Toronto, Ontario, Canada.

The renal and neurohumoral effects of prolonged cardiopulmonary baroreflex unloading and the relationship of these changes to urinary sodium excretion have not been well documented in humans. In this study, 12 normal males underwent lower body negative pressure at -15 mmHg for 90 min, a maneuver that deactivates cardiopulmonary baroreceptors. Glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and filtration fraction (FF) were measured in eight of these subjects using inulin and p-aminohippuric acid clearance techniques. During reduction of central venous pressure, arterial blood pressure and heart rate did not change. Plasma concentrations of atrial natriuretic factor (ANF) decreased markedly (22 +/- 2 to 12 +/- 1 pg/ml, P = 0.0001) as did the second messenger of ANF's biological action, guanosine 3',5'-cyclic monophosphate, whereas renin and vasopressin were not significantly altered. There was a significant rise in plasma norepinephrine (1.6 +/- 0.2 to 2.4 +/- 0.4 nmol/l, P = 0.03). GFR (104 +/- 9 to 68 +/- 6 ml/min, P = 0.007) and FF (0.18 +/- 0.01 to 0.14 +/- 0.01, P = 0.007) decreased significantly, with maintenance of ERPF. There was a significant antinatriuresis without an antikaliuresis and a significant reduction in free water clearance. These changes in renal hemodynamics are unlike the known effects of renal vasoconstrictors, and the alterations in solute and free water clearance are consistent with the removal of the known actions of ANF from tubular target sites. Taken together, our findings suggest that a mechanism other than activation of vasoconstrictors, possibly the diminution of the influence of ANF on the kidney, may be operative in the renal adjustments to cardiopulmonary baroreflex deactivation in humans.

This article has been cited by other articles:

				D. Z. I. Cherney, J. W. Scholey, D. C. Cattran, A. K. Kang, J. Zimpelmann, C. Kennedy, V. Lai, K. D. Burns, and J. A. Miller The effect of oral contraceptives on the nitric oxide system and renal function Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1539 - F1544. [Abstract] [Full Text] [PDF]

				A. Momen, K. Thomas, C. Blaha, A. Gahremanpour, A. Mansoor, U. A. Leuenberger, and L. I. Sinoway Renal vasoconstrictor responses to static exercise during orthostatic stress in humans: effects of the muscle mechano- and the baroreflexes J. Physiol., June 15, 2006; 573(3): 819 - 825. [Abstract] [Full Text] [PDF]

				M. Chidambaram, J. A. Duncan, V. S. Lai, D. C. Cattran, J. S. Floras, J. W. Scholey, and J. A. Miller Variation in the Renin Angiotensin System throughout the Normal Menstrual Cycle J. Am. Soc. Nephrol., February 1, 2002; 13(2): 446 - 452. [Abstract] [Full Text] [PDF]

				J. S. Floras, G. C. Butler, S.-I. Ando, S. C. Brooks, M. J. Pollard, and P. Picton Differential sympathetic nerve and heart rate spectral effects of nonhypotensive lower body negative pressure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R468 - R475. [Abstract] [Full Text] [PDF]

				T. Nishiyasu, N. Tan, K. Morimoto, R. Sone, and N. Murakami Cardiovascular and humoral responses to sustained muscle metaboreflex activation in humans J Appl Physiol, January 1, 1998; 84(1): 116 - 122. [Abstract] [Full Text] [PDF]